# EDGAR Filing Document

**Accession Number:** 0001205922
**File Stem:** 0001193125-23-017528
**Filing Date:** 2023-1
**Character Count:** 2248
**Document Hash:** 15b1151c8722f703ba70dc8aba0cf6c3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-017528.hdr.sgml**: 20230301

**ACCESSION NUMBER**: 0001193125-23-017528

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230127

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** VACCINEX, INC.
- **CENTRAL INDEX KEY:** 0001205922
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 161603202
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1895 MOUNT HOPE AVE
- **CITY:** ROCHESTER
- **STATE:** NY
- **ZIP:** 14620
- **BUSINESS PHONE:** 585-271-2700

**MAIL ADDRESS:**
- **STREET 1:** 1895 MOUNT HOPE AVE
- **CITY:** ROCHESTER
- **STATE:** NY
- **ZIP:** 14620

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** VACCINEX INC
- **DATE OF NAME CHANGE:** 20021114

**Vaccinex, Inc.** 

**1895 Mount Hope Avenue** 

**Rochester, New York 14620** 

January 27, 2023

***VIA EDGAR***

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Vaccinex, Inc.**  |

---

**Registration Statement on Form S-3** 

**Filed January 24, 2023** 

**File No. 333-269385** 

**Request for Acceleration of Effectiveness** 

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Vaccinex, Inc. hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-3 (the "<u>Registration Statement</u>") and declare the Registration Statement effective as of 4:30 p.m., Eastern Time, on January 31, 2023, or as soon thereafter as possible.

Please feel free to direct any questions or comments concerning this request to William Intner of Hogan Lovells US LLP at (410) 659-2778, and once the Registration Statement has been declared effective, please notify Mr. Intner by calling him at the same phone number.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| Vaccinex, Inc. | Vaccinex, Inc. |
| /s/ Scott E. Royer | /s/ Scott E. Royer |
| By: | Scott E. Royer |
| Title: | Chief Financial Officer |

---